Di Shen

Chinese Academy Of Medical Sciences And Peking Union Medical College, P.R. China
Beijing, 100021, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Long noncoding RNA XIST: a novel independent prognostic biomarker for patients with ABC-DLBCL receiving R-CHOP treatment.

Long noncoding RNA XIST: a novel independent prognostic biomarker for patients with ABC-DLBCL receiving R-CHOP treatment.

Journal: Carcinogenesis
Published: July 23, 2023

IGFBP3 Enhances Treatment Outcome and Predicts Favorable Prognosis in ABC-DLBCL.

IGFBP3 Enhances Treatment Outcome and Predicts Favorable Prognosis in ABC-DLBCL.

Journal: Journal of oncology
Published: September 19, 2022

Development of a novel five-lncRNA prognostic signature for predicting overall survival in elderly patients with breast cancer.

Development of a novel five-lncRNA prognostic signature for predicting overall survival in elderly patients with breast cancer.

Journal: Journal of clinical laboratory analysis
Published: October 11, 2021

Combination of Endogenous Estradiol and Adipokine Leptin in Breast Cancer Risk and Prognosis Assessment in Postmenopausal Chinese Women.

Combination of Endogenous Estradiol and Adipokine Leptin in Breast Cancer Risk and Prognosis Assessment in Postmenopausal Chinese Women.

Journal: Frontiers in endocrinology
Published: August 29, 2021

Serum KLKB1 as a Potential Prognostic Biomarker for Hepatocellular Carcinoma Based on Data-Independent Acquisition and Parallel Reaction Monitoring.

Serum KLKB1 as a Potential Prognostic Biomarker for Hepatocellular Carcinoma Based on Data-Independent Acquisition and Parallel Reaction Monitoring.

Journal: Journal of hepatocellular carcinoma
Published: June 23, 2021

CD24 Contributes to Treatment Effect in ABC-DLBCL Patients with R-CHOP Resistance.

CD24 Contributes to Treatment Effect in ABC-DLBCL Patients with R-CHOP Resistance.

Journal: Pharmacogenomics and personalized medicine
Published: March 15, 2021

Depth of Response and Early Tumor Shrinkage for Predicting Clinical Outcomes in HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab.

Depth of Response and Early Tumor Shrinkage for Predicting Clinical Outcomes in HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab.

Journal: Cancer management and research
Published: July 11, 2020

Eradication of Hepatitis C Virus (HCV) Improves Survival of Hepatocellular Carcinoma Patients with Active HCV Infection - A Real-World Cohort Study.

Eradication of Hepatitis C Virus (HCV) Improves Survival of Hepatocellular Carcinoma Patients with Active HCV Infection - A Real-World Cohort Study.

Journal: Cancer management and research
Published: March 19, 2020

Rapid identification of novel independent serum biomarkers in diffuse large B-cell lymphoma.

Rapid identification of novel independent serum biomarkers in diffuse large B-cell lymphoma.

Journal: Translational cancer research
Published: December 14, 2019

Identification of exosomal miRNAs associated with the anthracycline-induced liver injury in postoperative breast cancer patients by small RNA sequencing.

Identification of exosomal miRNAs associated with the anthracycline-induced liver injury in postoperative breast cancer patients by small RNA sequencing.

Journal: PeerJ
Published: October 04, 2019

Baseline Lymphopenia: A Predictor Of Poor Outcomes In HER2 positive Metastatic Breast Cancer Treated With Trastuzumab.

Baseline Lymphopenia: A Predictor Of Poor Outcomes In HER2 positive Metastatic Breast Cancer Treated With Trastuzumab.

Journal: Drug design, development and therapy
Published: April 17, 2019

Clinical features and treatment of patients with lung adenocarcinoma with bone marrow metastasis.

Clinical features and treatment of patients with lung adenocarcinoma with bone marrow metastasis.

Journal: Tumori
Published: April 02, 2019
Showing 1-12 of 16

Last Updated: 09/26/2026